Skip to main content
The Globe and Mail
Support Quality Journalism
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99 per week for the first 24 weeks
Just $1.99 per week for the first 24 weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); }
Coronavirus information
Coronavirus information
The Zero Canada Project provides resources to help you make the most of staying home.
Visit the hub

As countries begin to lift coronavirus lockdowns, biometric identification can help verify those who have already had the infection, and ensure that the vulnerable get the vaccine when it is launched, health and technology experts said.

Confirmed cases of COVID-19, the respiratory disease caused by the coronavirus, total more than 1.4 million, with about 82,000 deaths worldwide, according to a Reuters tally.

China lifted a two-month lockdown in the epicentre of Wuhan on Wednesday, and authorities in Britain and elsewhere said they would begin antibody tests to see whether people had been infected, to allow them to return to work or travel.

Story continues below advertisement

A biometric ID system can keep a record of such people and those getting the vaccine, said Larry Dohrs, Southeast Asia head at iRespond, a Seattle-based non-profit that launched its technology last month.

“We can biometrically identify the individual and tie them to the test results, as well as to a high security document. The person then has ‘non-refutable’ proof that they have immunity due to antibodies in their system,” he said.

“It would be a very valuable credential,” he told the Thomson Reuters Foundation. The non-profit already provides biometric IDs for refugees and stateless people.

From disinfecting drones to talking robots and artificial intelligence to develop vaccines, countries around the world have fast-tracked technology during the coronavirus outbreak.

Now, firms such as iRespond and Simprints – a UK-based non-profit that develops biometric IDs for health and humanitarian use – are adapting their technology for the next steps.

More than 1 billion people worldwide have no way of proving their identity, according to the World Bank.

This will present a massive challenge for governments trying to ascertain who has received the vaccine, said Prashant Yadav, a senior fellow at the U.S.-based Center for Global Development.

Story continues below advertisement

“The initial COVID-19 vaccine supply will be limited, so it will be essential to verify each dose reaches a real patient. Corruption, leakage, and even accidental duplication waste precious supply and are deadly,” he said.

“Biometric digital IDs can be a game-changer. They can help governments target population segments e.g. health care professionals or elderly population, verify people who have received vaccination, and have a clear record,” he said.

Digital identity systems are already in use in many countries, linking biometric data such as fingerprints and iris scans to a unique digital code, allowing for remote identification.

These can be leveraged for tracking vaccination too, Yadav said, although the vaccination infrastructure that is built around children will need to be retooled for adults.

Many biometric systems are also based on fingerprints, which can be a transmission risk for the coronavirus, so Simprints is developing a “touchless” technology that scans the face or the palm, said chief executive Toby Norman.

Such systems can also be abused by governments and private companies, according to digital rights groups which have raised concerns over the risk of increased surveillance.

Story continues below advertisement

To prevent any abuse, there has to be certainty about what the data will be used for and for how long, and when it will be deleted, said Norman.

“National governments don’t have a very good record of giving up new powers once a crisis has passed,” he said.

“Technology we use for disease surveillance today should not become tools for state surveillance at a later date.”

Sign up for the Coronavirus Update newsletter to read the day’s essential coronavirus news, features and explainers written by Globe reporters.

In the interests of public health and safety, our coronavirus news articles are free for anyone to access. However, The Globe depends on subscription revenue to support our journalism. If you are able, please subscribe to globeandmail.com. If you are already a subscriber, thank you for your support.

Your subscription helps The Globe and Mail provide readers with critical news at a critical time. Thank you for your continued support. We also hope you will share important coronavirus news articles with your friends and family. In the interest of public health and safety, all our coronavirus news articles are free for anyone to access.

Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies